Business Description
![Larimar Therapeutics Inc Larimar Therapeutics Inc logo](https://static.gurufocus.com/logos/0C0000BUPC.png?14)
Larimar Therapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US5171251003
Description
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 42.53 | |||||
Equity-to-Asset | 0.93 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.11 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 35.9 | |||||
3-Year EPS without NRI Growth Rate | 38.3 | |||||
3-Year FCF Growth Rate | 40.1 | |||||
3-Year Book Growth Rate | -31.7 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.2 | |||||
9-Day RSI | 45.6 | |||||
14-Day RSI | 46.45 | |||||
6-1 Month Momentum % | 87.3 | |||||
12-1 Month Momentum % | 196.75 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 17.99 | |||||
Quick Ratio | 17.99 | |||||
Cash Ratio | 17.7 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -41.9 | |||||
Shareholder Yield % | -33.28 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -36.86 | |||||
ROA % | -33.21 | |||||
ROIC % | -595.63 | |||||
ROC (Joel Greenblatt) % | -1452 | |||||
ROCE % | -40.07 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.11 | |||||
Price-to-Tangible-Book | 2.11 | |||||
EV-to-EBIT | -5.21 | |||||
EV-to-EBITDA | -5.24 | |||||
EV-to-FCF | -7.29 | |||||
Price-to-Net-Current-Asset-Value | 2.28 | |||||
Price-to-Net-Cash | 2.32 | |||||
Earnings Yield (Greenblatt) % | -19.19 | |||||
FCF Yield % | -7.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LRMR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Larimar Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.96 | ||
Beta | 1.03 | ||
Volatility % | 123.29 | ||
14-Day RSI | 46.45 | ||
14-Day ATR ($) | 0.678754 | ||
20-Day SMA ($) | 8.38725 | ||
12-1 Month Momentum % | 196.75 | ||
52-Week Range ($) | 2.18 - 13.68 | ||
Shares Outstanding (Mil) | 63.8 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Larimar Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Larimar Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Larimar Therapeutics Inc Frequently Asked Questions
What is Larimar Therapeutics Inc(LRMR)'s stock price today?
The current price of LRMR is $7.63. The 52 week high of LRMR is $13.68 and 52 week low is $2.18.
When is next earnings date of Larimar Therapeutics Inc(LRMR)?
The next earnings date of Larimar Therapeutics Inc(LRMR) is 2024-08-09 Est..
Does Larimar Therapeutics Inc(LRMR) pay dividends? If so, how much?
Larimar Therapeutics Inc(LRMR) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |